3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Thyroid Neoplasms
1
Tertiary Lymphoid Structures
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Lymphoma, T-Cell, Peripheral
1
Inhibition of Autophagy Synergizes Anti-tumor Effect
1
Immunoblastic Lymphadenopathy
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Digestive System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Biliary Tract Neoplasms
1
Advanced Solid Tumor Cancer
1
Interventions
Carboplatin
88
pembrolizumab
85
Paclitaxel
71
Cyclophosphamide
63
Capecitabine
38
Doxorubicin
37
Taxes
29
130-nm albumin-bound paclitaxel
29
Cisplatin
25
Albumin-Bound Paclitaxel
22
Epirubicin
21
Drug Therapy
21
Docetaxel
20
sacituzumab govitecan
19
olaparib
19
camrelizumab
18
atezolizumab
18
Gemcitabine
17
eribulin
16
durvalumab
16
Bevacizumab
16
Radiotherapy
15
toripalimab
14
Specimen Handling
14
Biopsy
13
Everolimus
12
Magnetic Resonance Spectroscopy
11
apatinib
10
Nivolumab
10
talazoparib
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Triple Negative Breast Neoplasms
×
Clinical Trials, Phase II as Topic
×
Clear all
NCT05491083
2025-07-25
ComPACT
National University Hospital, Singapore
Phase 1/2
Recruiting
51 enrolled
NCT03475953
2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2
Unknown
747 enrolled